| Bioactivity | BP Lipid 399 is derived from patent WO2020219876A1 (Example 3).BP Lipid 399 is an ionizable amino lipid analog of LP01 featuring a novel pyrrolidine head group three carbon atoms in length. This compound can be useful for the building or modification of lipid nanoparticles. |
| CAS | 1799316-96-3 |
| Formula | C50H91NO9 |
| Molar Mass | 850.26 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Compounds and compositions for intracellular delivery of therapeutic agents. WO2020219876A1 |
BP Lipid 399
CAS: 1799316-96-3 F: C50H91NO9 W: 850.26
BP Lipid 399 is derived from patent WO2020219876A1 (Example 3).BP Lipid 399 is an ionizable amino lipid analog of LP01 f
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.